Avecho Biotechnology Limited (AVE.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 175.15 Thousand AUD | -28.82% |
| 2022 | 246.07 Thousand AUD | 162.02% |
| 2021 | 93.91 Thousand AUD | -43.5% |
| 2020 | 166.23 Thousand AUD | 71.04% |
| 2019 | 97.18 Thousand AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| 2002 | - AUD | -100.0% |
| 2001 | 39.19 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | -100.0% |
| 1995 | 1000.00 AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 137.41 Thousand AUD | 0.0% |
| 2023 FY | 175.15 Thousand AUD | -28.82% |
| 2023 Q2 | 211.08 Thousand AUD | 0.0% |
| 2023 Q4 | 175.15 Thousand AUD | 0.0% |
| 2022 Q2 | 54.08 Thousand AUD | 0.0% |
| 2022 FY | 246.07 Thousand AUD | 162.02% |
| 2022 Q4 | 246.07 Thousand AUD | 0.0% |
| 2021 Q4 | 93.91 Thousand AUD | 0.0% |
| 2021 FY | 93.91 Thousand AUD | -43.5% |
| 2021 Q2 | 131.01 Thousand AUD | 0.0% |
| 2020 Q2 | 53.15 Thousand AUD | 0.0% |
| 2020 FY | 166.23 Thousand AUD | 71.04% |
| 2020 Q4 | 166.23 Thousand AUD | 0.0% |
| 2019 Q4 | 97.18 Thousand AUD | 0.0% |
| 2019 FY | 97.18 Thousand AUD | 0.0% |
| 2019 Q2 | 51.6 Thousand AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2002 FY | - AUD | -100.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2001 Q4 | 39.19 Thousand AUD | 0.0% |
| 2001 FY | 39.19 Thousand AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1996 FY | - AUD | -100.0% |
| 1995 FY | 1000.00 AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -41.415% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 96.902% |
| Biome Australia Limited | 1.3 Million AUD | 86.586% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | 74.604% |
| Imugene Limited | 1.54 Million AUD | 88.677% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | 84.26% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | 47.002% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | 44.642% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.999% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | 80.092% |
| Starpharma Holdings Limited | 3.52 Million AUD | 95.035% |
| Nanollose Limited | 42.53 Thousand AUD | -311.829% |
| Memphasys Limited | 4.41 Million AUD | 96.031% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 88.785% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | 58.492% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 98.996% |
| Dimerix Limited | 149.68 Thousand AUD | -17.015% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | 85.74% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -10.127% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 88.221% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -2356.536% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 92.979% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -642.417% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | 26.816% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | 78.408% |
| Actinogen Medical Limited | 319.06 Thousand AUD | 45.106% |
| Immuron Limited | 173.49 Thousand AUD | -0.953% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |